NUE vs TBPH · P/E 25, rev $19.89B vs P/E 7.5, rev $38.4M
Nucor Corp (NUE) versus Theravance Biopharma Inc (TBPH) — a side-by-side from cached financials, not a winner call.
Nucor Corp (NUE) is a steel company listed on NYSE.
Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
Latest reported NUE revenue for 2026-07-04 was $19.89B. Net income was $1.90B. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
Latest reported TBPH revenue for 2026-06-30 was $38.4M. Net income was -$10.8M. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
NUE currently screens at market cap $57.53B and trailing P/E 25.1. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
Not investment advice. Open the NUE and TBPH stock pages for the full models.
Not investment advice.